Alopecia with Vitamin D-Dependent Rickets Type 2 A: A Case Report
Nouf Bin Rubaian,Bashayer Al-Awam,Samah M Aljohani,Serene R Almuhaidib
DOI: https://doi.org/10.2147/ccid.s438505
2024-01-03
Clinical Cosmetic and Investigational Dermatology
Abstract:Nouf F Bin Rubaian, 1 Bashayer S Al-Awam, 2 Samah M Aljohani, 1 Serene R Almuhaidib 3 1 Department of Dermatology, King Fahad University Hospital, Al Khobar, Saudi Arabia; 2 Department of Pediatrics, King Fahad University Hospital, Al Khobar, Saudi Arabia; 3 Department of Dermatology, Dammam Medical Complex, Dammam, Saudi Arabia Correspondence: Serene R Almuhaidib, Department of Dermatology, Dammam Medical Complex, Dammam, Saudi Arabia, Email Vitamin D-dependent rickets type II (VDDR2) is a rare inherited autosomal recessive disorder wherein the genetic mutation results in a defect in the vitamin D receptor (VDR), thus leading to target resistance to 1.25-dihydroxy vitamin D. This results in hypocalcemia, hypophosphatemia, secondary hyperparathyroidism, and rickets. We report a case of a four-year-old female child with diffuse alopecia starting 2 weeks after birth, along with frontal bossing, hypoplastic teeth, and an unusual presentation of multiple skin-colored papules over the back. Genetic testing confirmed vitamin D-dependent rickets type 2A. Keywords: pseudovitamin D-deficiency, rickets-alopecia syndrome, hypocalcemic vitamin D-resistant rickets, genetic mutation Vitamin D-dependent rickets type II (VDDR2) is an inherited rare autosomal recessive disorder. 1 This condition is also known as pseudovitamin D-deficiency Type 2, hypocalcemic vitamin D-resistant rickets, or rickets-alopecia syndrome. 1 The genetic mutation in chromosomes 12q12-q14 leads to a defect in the vitamin D receptor (VDR), resulting in a target resistance to 1.25-dihydroxyvitamin D, resulting in hypocalcemia, hypophosphatemia, secondary hyperparathyroidism, and rickets. 1 Two decades ago, the prevalence of vitamin D-dependent rickets, in all of its types, was approximately 30%; however, in the present time, it has reduced to 0.8%. 2 The condition is characterized by a diminished response of organs to vitamin D. Its typical manifestation involves complete body hair loss and the development of rickets in the latter part of the first year of life. Individuals with this disorder may exhibit ongoing rachitic alterations in bones, leading to weakened bones, which in turn contribute to delayed growth, bone discomfort, reduced height, and bowed legs. 3 Depending on the presence or absence of alopecia, it is further classified as VDDR type IIA or IIB, respectively. 3 A four-year-old female child was brought by her family complaining of hair loss over the scalp that started 2 weeks after delivery, with a history of diffuse hair loss over eyebrows and eyelashes. The patient has also been diagnosed with rickets due to walking difficulties in the first year of life. The patient's parents are cousins, and these abnormalities were not detected among the parents or the younger sibling. On clinical examination, both height and weight were below the third percentile, and alopecia was observed including loss of hair on the scalp, eyelids, and the entire body with few terminal hairs observed over the vertex, eyebrows, and eyelashes (Figure 1). The patient had features of rickets including frontal bossing (Figure 2A) and hypoplastic teeth (Figure 2B). The patient developed these multiple skin-colored papules over the back (Figure 2C) 1 month ago which was confusing for congenital atrichia with papules. Trichoscopy findings showed absent follicular hair ostia (Figure 3). A hair examination was done under light microscopy to exclude other hair shaft disorders before genetic testing. Hair pull test to exclude loose anagen phase. Figure 1 Diffuse alopecia with few terminal hairs. ( A ) Fronal view, ( B ) Vertex view. Figure 2 ( A ) Frontal bossing, ( B ) Hypoplastic teeth, ( C ) Multiple skin-colored papules over the back. Figure 3 Trichoscopy findings. ( A ) Preserved follicular Ostia but empty ( B ) The anagen hair root is pigmented and covered by sheath. On investigations, initial calcium level revealed hypocalcemia (serum calcium levels: 6.8 mg/dL; reference range: 8.8–10.6 mg/dL) and increased alkaline phosphatase levels were observed (580 IU/L; reference range: 50–155 IU/L). Phosphorus (3.8 mg/dl; reference range: 3.4–4.5 mg/dL), parathyroid hormone level (225 pg/mL). The patient was started on 1-Alpha 1 mcg twice per day in addition to Calcic 5 mL twice per day. After 6 months of treatment, serum calcium was found to increase to normal levels. On the other hand, alkaline phosphatase level decreased and parathyroid hormone levels increased. X-ray of both hands showed ossification of the capitate, hamate, triquetrum, and trapezium bones only. Delayed appearance -Abstract Truncated-
dermatology